RxDoctor Payments Data

Richard Fortunato, DO

Colon & Rectal Surgery · Pittsburgh, PANPI 1033375894

Payments from drug & device makers

What this record shows

The money is spread across several categories — education (30.9%), speaking fees and consulting fees — rather than concentrated in one kind of arrangement. 25 manufacturers reported payments, led by Integra Lifesciences Corporation at 46.5% of the total. Reporting peaked in 2024 at $23,798 and has fallen 61.9% since, to $9,067 in 2025. Among colon & rectal surgery clinicians in PA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$80,421in general payments, 2019–2025

Across 184 payments — averaging $437.07 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Integra Lifesciences Corporation$37K
  • Intuitive Surgical$34K
  • Acell, Inc.$5K
  • Medtronic$799
  • Innovation Technologies Inc$665
  • Covidien LP$384
  • plus $2K from 19 others

What the payments were for

  • Consulting fees$17,06321%
  • Speaking & faculty fees$19,65524%
  • Travel & lodging$7,0029%
  • Food & beverage$9,56112%
  • Education$24,82431%
  • Other$2,3163%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$80,421 in reported general payments places this provider in the 95th percentile of 108 colon & rectal surgery providers in Pennsylvania.

See all colon & rectal surgery providers in Pennsylvania

Medicare billing

Part B allowed, 2024
$80,746
Medicare patients
138
Services billed
347

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Sod Sulf-Potass Sulf-Mag SulfSodium, Potassium,mag Sulfates81$5,545
LoperamideLoperamide Hcl14$1,076

Paid to pharmacies, not to this prescriber.

Other colon & rectal surgery in Pittsburgh

See the full list for Pennsylvania

Where these figures come from

Is this you, or does something look wrong? →